1-hydroxypyrene has been researched along with Psoriasis in 8 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 1 (12.50) | 18.7374 |
1990's | 3 (37.50) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 4 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Andrys, C; Borska, L; Borsky, P; Fiala, Z; Hamakova, K; Krejsek, J; Kremlacek, J; Ranna, D | 1 |
Andrys, C; Borska, L; Borsky, P; Fiala, Z; Hamakova, K; Krejsek, J; Kremlacek, J; Palicka, V; Vorisek, V | 1 |
Andrys, C; Borska, L; Fiala, Z; Hamakova, K; Krejsek, J; Kremlacek, J; Palicka, V; Ranna, D | 1 |
Aben, KK; Anzion, R; Dettbarn, G; Godschalk, R; Golsteijn, L; Kiemeney, LA; Roelofzen, JH; Scheepers, PT; Seidel, A; van der Valk, PG; van Schooten, FJ | 1 |
Beachman, A; Blaskovic, R; DeLeo, VA; Lin, JH; Nunes, MG; Perera, FP; Santella, RM; Tang, D | 1 |
Hansen, AM; Menné, T; Poulsen, OM | 1 |
Clonfero, E; Granella, M | 1 |
Anzion, RB; Bos, RP; Clonfero, E; Cottica, D; Jongeneelen, FJ; Levis, AG; Paleologo, M; Pozzoli, L; Venier, P; Zordan, M | 1 |
8 other study(ies) available for 1-hydroxypyrene and Psoriasis
Article | Year |
---|---|
Elevated levels of circulating biomarkers of cell death (nucleosomes) in the patients with plaque psoriasis treated with the Goeckerman regimen.
Topics: Biomarkers; Cell Death; Humans; Nucleosomes; Psoriasis; Pyrenes; Ultraviolet Therapy | 2014 |
Influence of dermal exposure to ultraviolet radiation and coal tar (polycyclic aromatic hydrocarbons) on the skin aging process.
Topics: Administration, Cutaneous; Adult; Aged; Biomarkers; Chronic Disease; Coal Tar; Combined Modality Therapy; DNA Damage; Female; Humans; Keratolytic Agents; Male; Middle Aged; Oxidative Stress; Polycyclic Aromatic Hydrocarbons; Psoriasis; Pyrenes; RNA Stability; Skin Aging; Smoking; Time Factors; Treatment Outcome; Ultraviolet Therapy; Vitamin D; Whole-Body Irradiation; Young Adult | 2016 |
Genotoxic and apoptotic effects of Goeckerman therapy for psoriasis.
Topics: Adolescent; Adult; Aged; Apoptosis; Chromosome Aberrations; Coal Tar; DNA Damage; Fas Ligand Protein; Humans; Lymphocytes; Middle Aged; Polycyclic Aromatic Hydrocarbons; Psoriasis; Pyrenes; Skin Absorption; Tumor Suppressor Protein p53; Ultraviolet Therapy; Young Adult | 2010 |
DNA adducts in skin biopsies and 1-hydroxypyrene in urine of psoriasis patients and healthy volunteers following treatment with coal tar.
Topics: Adolescent; Adult; Aged; Biopsy; Case-Control Studies; Coal Tar; DNA Adducts; Humans; Male; Middle Aged; Psoriasis; Pyrenes; Skin; Young Adult | 2012 |
Quantitation of polycyclic aromatic hydrocarbons, 1-hydroxypyrene, and mutagenicity in urine of coal tar-treated psoriasis patients and untreated volunteers.
Topics: Administration, Topical; Adult; Chromatography, High Pressure Liquid; Coal Tar; Dose-Response Relationship, Drug; Enzyme-Linked Immunosorbent Assay; Female; Humans; Male; Middle Aged; Mutagenicity Tests; Mutagens; Polycyclic Compounds; Psoriasis; PUVA Therapy; Pyrenes; Salmonella typhimurium | 1994 |
Longitudinal study of excretion of metabolites of polycyclic aromatic hydrocarbons in urine from two psoriatic patients.
Topics: Adult; Coal Tar; Female; Humans; Longitudinal Studies; Male; Middle Aged; Mutagens; Naphthols; Polycyclic Compounds; Psoriasis; Pyrenes | 1993 |
Sensitivity of different bacterial assays in detecting mutagens in urine of humans exposed to polycyclic aromatic hydrocarbons.
Topics: Coal Tar; Creatinine; Environmental Monitoring; Humans; Mutagenicity Tests; Mutagens; Polycyclic Compounds; Psoriasis; Pyrenes; Salmonella typhimurium; Sensitivity and Specificity; Urine | 1992 |
Biological monitoring of human exposure to coal tar. Urinary excretion of total polycyclic aromatic hydrocarbons, 1-hydroxypyrene and mutagens in psoriatic patients.
Topics: Coal Tar; Environmental Exposure; Humans; Male; Monitoring, Physiologic; Mutagenicity Tests; Mutagens; Polycyclic Compounds; Psoriasis; Pyrenes | 1989 |